Journey Medical Corp. (DERM)
3.45
-0.10
(-2.82%)
USD |
NASDAQ |
Nov 20, 10:20
Journey Medical Cash from Operations (Quarterly) : -3.437M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.437M |
| June 30, 2026 | -1.734M |
| March 31, 2026 | 2.909M |
| December 31, 2025 | -6.359M |
| September 30, 2025 | -2.383M |
| June 30, 2025 | -0.942M |
| March 31, 2025 | -2.832M |
| December 31, 2024 | 2.225M |
| September 30, 2024 | -1.157M |
| June 30, 2024 | -5.176M |
| March 31, 2024 | -5.019M |
| December 31, 2023 | -16.43M |
| September 30, 2023 | 18.75M |
| Date | Value |
|---|---|
| June 30, 2023 | 3.878M |
| March 31, 2023 | -0.956M |
| December 31, 2022 | -3.836M |
| September 30, 2022 | -7.282M |
| June 30, 2022 | -3.30M |
| March 31, 2022 | 0.884M |
| December 31, 2021 | -3.206M |
| September 30, 2021 | 7.102M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 5.054M |
| September 30, 2020 | -1.071M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Talphera, Inc. | -3.034M |
| Fortress Biotech, Inc. | -6.197M |
| Relmada Therapeutics, Inc. | -12.59M |
| Turn Therapeutics, Inc. | -1.549M |
| ANI Pharmaceuticals, Inc. | 83.79M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.117M |
| Free Cash Flow | -8.621M |
| Free Cash Flow Per Share (Quarterly) | -0.1224 |
| Free Cash Flow to Equity (Quarterly) | -3.517M |
| Free Cash Flow to Firm (Quarterly) | -2.518M |
| Free Cash Flow Yield | -8.85% |